Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis.

Genetics and molecular research : GMR - 22 Mar 2017

Cao H Y, Yang S, Wang S, Deng L Y, Lou J Y

Abstract excerpt

We conducted a meta-analysis to examine p16INK4a expression in uterine smooth muscle tumors (USMTs). Although the prognostic value of tumor suppressor p16INK4a has been elucidated in a variety of cancers and precancerous lesions, its role in USMTs is not well established. We searched PubMed, Web of Science, and Embase for publication son p16INK4a expression in USMTs. Strict inclusion and exclusion criteria were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p16

Share to Leiomyoma

Share to Leiomyosarcoma

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Uterine Neoplasms

Source

Identifiers

PMID: 28340268
DOI: 10.4238/gmr16019481

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis.PMID 28340268Read ↗

Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.Semantic proximity Read ↗

Challenges in identifying biomarkers for Smooth muscle tumors of uncertain malignant potential (STUMP)Semantic proximity Read ↗

Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis.Semantic proximity Read ↗

Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesionsSemantic proximity Read ↗

Expression of Subtype-Specific Group 1 Leiomyosarcoma Markers in a Wide Variety of Sarcomas by Gene Expression Analysis and ImmunohistochemistrySemantic proximity Read ↗

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.Semantic proximity Read ↗

β-catenin is a potential prognostic biomarker in uterine sarcomaSemantic proximity Read ↗

MiR-142-3p May Be Involved in the Development of Solitary and Multiple Uterine Leiomyomasby Interacting with CTNNB1 and AXIN-2 Through Wnt Signaling PathwaySemantic proximity Read ↗

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.Semantic proximity Read ↗

Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical applicationSemantic proximity Read ↗

FGF23 is a potential prognostic biomarker in uterine sarcomaSemantic proximity Read ↗

Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.